News | September 30, 2023
Advent International announces the completion of the acquision of Suven Pharma
New Board of Directors and management team at Suven Pharma also appointed
New Board of Directors and management team at Suven Pharma also appointed
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
30 beneficiaries avail of services per minute
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies
The companies will work with investigators to share the results with the scientific community
Subscribe To Our Newsletter & Stay Updated
